Literature DB >> 25175094

Best practice for atrial fibrillation patient education.

Deirdre A Lane, Rachel V Barker, Gregory Y H Lip1.   

Abstract

Patients' beliefs about their health (and illness), medications and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses in relation to their illness; make them adhere to recommended therapy and ultimately affect health outcomes. Incorporation of patients' preferences for therapy should now be considered an integral part of the decision-making process. This gradual shift in health-care practice from paternalistic to shared-decision making, whereby there is a two-way exchange of information between the patient and healthcare provider and both are involved in the treatment decision, requires a reasonable level of understanding and knowledge of the condition and its treatment by the patient. However, patients with atrial fibrillation (AF) often have poor knowledge about their condition and the benefits and risks of AF and AF treatments. Physicians and other healthcare providers may have doubts over a patient's ability to adhere to certain treatment regimens, particularly oral anticoagulation, due in part to the lack of patient knowledge, and this may be an important determinant of whether such treatments are even considered as therapeutic options. Further, patients often hold misconceptions about AF and treatment options, which may act as barriers to their acceptance of the condition and adherence to therapy. This review will summarise the literature on the knowledge of patients about AF and its management, how patients' values and preferences can impact on their treatment choices, the ideal components of patient education, the impact of educational interventions on patients' knowledge and perceptions of AF, and where appropriate highlight specific issues facing lone AF patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25175094     DOI: 10.2174/1381612820666140825125715

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

1.  Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization study.

Authors:  Zhiyan Liu; Qiufen Xie; Qian Xiang; Hanxu Zhang; Guangyan Mu; Zinan Zhao; Taotao Hu; Tingting Wu; Na Wang; Jinhua Zhang; Yan Qian; Shuang Zhou; Zining Wang; Jie Jiang; Yatong Zhang; Hongtao Song; Yimin Cui
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

2.  Developing a Complex Educational-Behavioural Intervention: The TREAT Intervention for Patients with Atrial Fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Christian Borg Xuereb; Deirdre A Lane
Journal:  Healthcare (Basel)       Date:  2016-01-14

3.  Atrial Fibrillation in Hypertension: Patients' Characteristics.

Authors:  Styliani Koutsaki; Ioannis Koutelekos; Georgia Gerogianni; Maria Koutsaki; Aggeliki Koukouzeli; Georgia Fouka; Maria Polikandrioti
Journal:  Mater Sociomed       Date:  2018-03

Review 4.  Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.

Authors:  Tatjana S Potpara; Nikolaos Dagres; Nebojša Mujović; Dragan Vasić; Milika Ašanin; Milan Nedeljkovic; Francisco Marin; Laurent Fauchier; Carina Blomstrom-Lundqvist; Gregory Y H Lip
Journal:  Adv Ther       Date:  2016-12-08       Impact factor: 3.845

5.  Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.

Authors:  David Zweiker; Robert Zweiker; Elisabeth Winkler; Konstantina Roesch; Martin Schumacher; Vinzenz Stepan; Peter Krippl; Norbert Bauer; Martin Heine; Gerhard Reicht; Gudrun Zweiker; Martin Sprenger; Norbert Watzinger
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

6.  Protocol of a clinical trial study involving educational intervention in patients treated with warfarin.

Authors:  Josiane Moreira da Costa; Milena Soriano Marcolino; Heloisa Carvalho Torres; Raissa Eda de Resende; Renan Pedra de Souza; Hannah Cardoso Barbosa; Daniel Dias Ribeiro; Maria Auxiliadora Parreiras Martins
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.

Authors:  José Maria Farinha; Ian D Jones; Gregory Y H Lip
Journal:  Eur Heart J Suppl       Date:  2022-02-14       Impact factor: 1.803

Review 8.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

Authors:  Hans-Christoph Diener; James Aisenberg; Jack Ansell; Dan Atar; Günter Breithardt; John Eikelboom; Michael D Ezekowitz; Christopher B Granger; Jonathan L Halperin; Stefan H Hohnloser; Elaine M Hylek; Paulus Kirchhof; Deirdre A Lane; Freek W A Verheugt; Roland Veltkamp; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

9.  Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population.

Authors:  Ina Qvist; Jeroen M L Hendriks; Dorthe S Møller; Andi E Albertsen; Helle M Mogensen; Gitte D Oddershede; Annette Odgaard; Leif Spange Mortensen; Søren Paaske Johnsen; Lars Frost
Journal:  Open Heart       Date:  2016-01-13

10.  Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.

Authors:  Deirdre A Lane; Juliane Meyerhoff; Ute Rohner; Gregory Y H Lip
Journal:  Clin Cardiol       Date:  2018-06-12       Impact factor: 2.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.